抗TNF-β抗体(Anti-TNF-β, Human, Mouse-Mono antibody)

掲載日情報:2018/11/26 現在Webページ番号:28187

TNF-βに対する抗体(Anti-TNF-β, Human, Mouse-Mono )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2026年04月06日 15時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-TNF-β, Human, Mouse-Mono(5802.21)
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 1
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
別名:LT
クローン:5802
Genbank No: 4049
Protein Accession No: P01374
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Mouse クラス IgG 標識 Unlabeled
交差性 Human 適用 IC,Neutralising
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 Helper T Cells Marker Antibodies
関連記事
Anti-Human Lymphotoxin-alpha/TNF-beta MAb (Clone 5802)
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 1
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
※受注発注品。形状:溶液または凍結乾燥
別名:LT
クローン:5802
Genbank No: 4049
Protein Accession No: P01374
別包装品 別包装品あり
法規制等
保存条件 法規備考
抗原種 免疫動物 Mouse クラス IgG 標識 Unlabeled
交差性 Human 適用 IC,Neutralising
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 Helper T Cells Marker Antibodies
使いっきり抗体
関連記事

[在庫・価格 :2026年04月06日 15時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-TNF-β, Human, Mouse-Mono(5802.21)

文献数: 1

説明文 別名:LT
クローン:5802
Genbank No: 4049
Protein Accession No: P01374
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Mouse
交差性 Human 適用 IC,Neutralising
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 Helper T Cells Marker Antibodies
関連記事

Anti-Human Lymphotoxin-alpha/TNF-beta MAb (Clone 5802)

文献数: 1

説明文 ※受注発注品。形状:溶液または凍結乾燥
別名:LT
クローン:5802
Genbank No: 4049
Protein Accession No: P01374
別包装品 別包装品あり
法規制等
保存条件 法規備考
抗原種 免疫動物 Mouse
交差性 Human 適用 IC,Neutralising
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 Helper T Cells Marker Antibodies
使いっきり抗体
関連記事



目次に戻る

Product Details

Species ReactivityHuman
LabelUnconjugated
ImmunogenE. coli-derived recombinant human Lymphotoxin‑ alpha /TNF‑ beta Leu35-Leu205Accession # P01374
SourceMonoclonal Mouse IgG1 Clone # 5802
PurificationProtein A or G purified from ascites
SpecificityDetects human Lymphotoxin‑ alpha /TNF‑ beta in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) TNF-alpha is observed. Neutralizes the biological activity of recombinant human TNF-beta. Will not neutralize the biological activity of recombinant human TNF-alpha or recombinant mouse TNF-alpha.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Immunocytochemistry8-25 µg/mLSee below
NeutralizationMeasured by its ability to neutralize Lymphotoxin‑ alpha /TNF‑ beta -induced cytotoxicity in the L‑929 mouse fibroblast cell line. Matthews, N. and M. L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M. J. et al. (eds): IRL Press. 221. The Neutralization Dose (ND50) is typically 0.1-0.2 µg/mL in the presence of 0.25 ng/mL Recombinant Human Lymphotoxin‑ alpha /TNF‑ beta and 1 µg/mL actinomycin D.


Neutralization
Cytotoxicity Induced by Lymphotoxin‑ alpha /TNF‑ beta  and Neutral­ization by Human Lymphotoxin‑ alpha /TNF‑ beta Antibody.
Recombinant Human Lymphotoxin‑ alpha /TNF‑ beta (Catalog # 211‑TB) induces cytotoxicity in the the L‑929 mouse fibroblast cell line in a dose-dependent manner (orange line), as measured by crystal violet staining. Cytotoxicity elicited by Recombinant Human Lymphotoxin‑ alpha /TNF‑ beta (0.25 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human Lymphotoxin‑ alpha /TNF‑ beta Monoclonal Antibody (Catalog # MAB211). The ND50 is typically 0.1‑0.2 µg/mL in the presence of the metabolic inhibitor actinomycin D (1 µg/mL).
Immunocytochemistry
Lymphotoxin‑ alpha /TNF‑ beta  in Human PBMCs.
Lymphotoxin‑ alpha /TNF‑ beta was detected in immersion fixed human peripheral blood mononuclear cells (PBMCs) stimulated with LPS and monensin using Mouse Anti-Human Lymphotoxin‑ alpha /TNF‑ beta Monoclonal Antibody (Catalog # MAB211) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counter­stained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Non-adherent Cells.


目次に戻る

Related Product & Information

Long NameTumor Necrosis Factor beta
Entrez Gene IDs4049 (Human); 16992 (Mouse)
BackgroundLymphotoxin-alpha/TNF-beta
background_contentBackground:
Lymphotoxin-alpha/TNF-beta
Tumor necrosis factor beta (TNF-beta ), also known as lymphotoxin-alpha (LT-alpha ), and TNF-alpha, are two structurally and functionally related proteins that bind to the same cell surface receptors (TNF RI and TNF RII) and produce a vast range of similar, but not identical, effects. Among these effects is the ability to kill certain tumor cells directly, from which the names tumor necrosis factor and lymphotoxin both derive. Mature TNF-beta /LT-alpha and TNF-alpha share approximately 35% protein sequence homology and the biologically active secreted forms of both proteins are homotrimers. Whereas TNF-alpha can exist as a type II membrane protein, TNF-beta /LT-alpha possesses a typical signal peptide sequence and is a secreted protein. It has been shown that TNF-beta /LT-alpha is also present on the cell surface of activated T, B and LAK cells as a heteromeric complex with LT-beta, a type II membrane protein that is another member of the TNF ligand family. The genes for TNF-alpha, TNF-beta /LT-alpha, and LT-beta are closely linked within the major histocompatibility complex. TNF-beta /LT-alpha is expressed in activated T- and B-lymphocytes. In addition to its cytotoxic action on tumor cells, TNF-beta /LT-alpha has been shown to be a mediator of inflammation and immune function. Evidence is also accumulating that TNF-beta /LT-alpha and TNF-alpha are mediators in the pathogenesis of certain autoimmune diseases. TNF-beta /LT-alpha has also been shown to have a role in lymphoid organ development. Human and mouse TNF-beta /LT-alpha share approximately 74% homology in their amino acid sequence and exhibit cross-species activity.


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
  1. True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?
    Authors: Buch MH, Conaghan PG, Quinn MA, Bingham SJ, Veale D, Emery P
    Ann. Rheum. Dis., 2004;63(10):1344-6.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC Frozen



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。